XERS
Xeris Biopharma Holdings, Inc. · Healthcare · Biotechnology
Input momentum (manajer yang sebanding): keluasan pemegang 0.0% · aliran saham +2.0% · posisi baru bersih -5.9% · formula
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q3 2025
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 50.72K | $516,766 | n/a | n/a |
| Q2 2026 | 94 | +4 | 81.60M | $645.79M | +9 | −4 |
| Q1 2026 | 92 | +4 | 77.44M | $449.36M | +7 | −4 |
| Q4 2025 | 88 | +2 | 77.86M | $611.14M | +3 | n/a |
| Q3 2025 | 17 | 0 | 48.63M | $395.88M | +1 | −2 |
| Q2 2025 | 15 | -1 | 41.39M | $193.31M | n/a | −1 |
| Q1 2025 | 13 | +3 | 18.95M | $104.02M | +4 | −1 |
| Q4 2024 | 10 | +1 | 14.55M | $49.32M | +1 | n/a |
| Q3 2024 | 8 | -1 | 9.23M | $26.32M | n/a | −1 |
| Q2 2024 | 9 | n/a | 8.75M | $19.69M | n/a | n/a |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (pasif) | 11.93M | +3.4% | $97.09M | 0.0% | ▲ Add | 2 | SEC ↗ ×10 |
| 2 | The Vanguard Group ✦ (pasif) | 9.83M | +0.1% | $80.00M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 3 | D. E. Shaw & Co. ✦ | 5.84M | +52.3% | $47.54M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 4 | Geode Capital Management ✦ (pasif) | 4.14M | +13.4% | $33.71M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 5 | State Street Global Advisors ✦ (pasif) | 3.74M | -1.2% | $30.43M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 6 | Morgan Stanley ✦ | 3.22M | n/a | $26.21M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 7 | JPMorgan Chase ✦ | 1.81M | n/a | $14.73M | 0.0% | n/c | 1 | SEC ↗ ×12 |
| 8 | Goldman Sachs Group ✦ | 1.80M | n/a | $14.62M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 9 | Renaissance Technologies ✦ | 1.62M | -21.0% | $13.21M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 10 | Two Sigma Investments ✦ | 1.61M | +32.9% | $13.14M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 983.60K | -6.2% | $8.01M | 0.0% | ▼ Trim | 6 | SEC ↗ ×4 |
| 12 | Wellington Management ✦ | 580.96K | +45.5% | $4.73M | 0.0% | ▲ Add | 6 | SEC ↗ ×5 |
| 13 | Millennium Management ✦ | 524.75K | -82.1% | $4.27M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 437.61K | Baru | $3.56M | 0.0% | New | 1 | SEC ↗ |
| 15 | Fidelity (FMR) ✦ | 360.18K | +10.3% | $2.93M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 16 | T. Rowe Price ✦ | 166.79K | +8.8% | $1.36M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 17 | Gotham Asset Management ✦ | 42.74K | +30.4% | $347,912 | 0.0% | ▲ Add | 3 | SEC ↗ |
"Their weight" = porsi posisi dari nilai ekuitas 13F yang dilaporkan manajer tersebut: ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Citadel Advisors | $3.56M | 0.0% |
Telah keluar
| Norges Bank | $2.62M | adalah 0.0% |
| Point72 Asset Management | $210,617 | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 229 pemegang, 93.59M saham, $532.36M dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang sekuritas ini yang dilacak: jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Officer · 25.00K lbr · $250,000
Officer · 16.67K lbr · $141,434
Officer · 15.00K lbr · $127,308
Officer · 5.00K lbr · $42,500
Officer · 5.00K lbr · $42,500
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi